Not applicableWithdrawnNCT02020109What this trial is testingEvaluation of Splenic Irradiation in Chronic Lymphatic LeukemiaWho this might be right forLeukemia, Chronic Lymphatic Maastricht Radiation Oncology
Testing effectiveness (Phase 2)Study completedNCT00759798What this trial is testingIdentifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic LeukemiaLeukemia M.D. Anderson Cancer Center 289
Early research (Phase 1)Looking for participantsNCT06980116What this trial is testingDose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell MalignanciesWho this might be right forRelapsed or Refractory B-cell MalignanciesChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Follicular Lymphoma (FL)+4 more Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 85
Early research (Phase 1)UnknownNCT00004036What this trial is testingCombination Chemotherapy Plus Amifostine in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more The Cleveland Clinic 30
Testing effectiveness (Phase 2)Study completedNCT01363128What this trial is testingCombination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaWho this might be right forAcute Lymphoblastic LeukemiaAdult Acute Lymphoblastic Leukemia in Complete RemissionBurkitt Leukemia+4 more M.D. Anderson Cancer Center 72
Testing effectiveness (Phase 2)Study completedNCT01063907What this trial is testingKW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Kyowa Kirin Co., Ltd. 95
Early research (Phase 1)Study completedNCT00020111What this trial is testingArsenic Trioxide in Treating Young Patients With Refractory Leukemia or LymphomaWho this might be right forLeukemiaLymphoma National Cancer Institute (NCI)
Testing effectiveness (Phase 2)WithdrawnNCT02285244What this trial is testingSotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's TransformationWho this might be right forProlymphocytic LeukemiaRecurrent Mantle Cell LymphomaRecurrent Small Lymphocytic Lymphoma+2 more James Blachly
Testing effectiveness (Phase 2)Study completedNCT00004857What this trial is testingFludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic LeukemiaWho this might be right forLeukemia Alliance for Clinical Trials in Oncology 86
Testing effectiveness (Phase 2)Looking for participantsNCT07108998What this trial is testingStudy of Epcoritamab as a Consolidation Therapy in CLL/SLLWho this might be right forCLL/SLLCLLSLL+4 more Zulfa Omer 22
Early research (Phase 1)Study completedNCT00053963What this trial is testingFR901228 in Treating Children With Refractory or Recurrent Solid Tumors or LeukemiaWho this might be right forBlastic Phase Chronic Myelogenous LeukemiaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more National Cancer Institute (NCI) 30
Not applicableLooking for participantsNCT06784167What this trial is testingVaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T TreatmentWho this might be right forChronic Lymphocytic LeukemiaDiffuse Large B-Cell LymphomaFollicular Lymphoma+4 more OHSU Knight Cancer Institute 45
Early research (Phase 1)Study completedNCT00641381What this trial is testingCarmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated LymphomaWho this might be right forLymphoma City of Hope Medical Center 25
Not applicableStudy completedNCT02434484What this trial is testingSymbenda Post-Marketing Surveillance (PMS)Who this might be right forLymphoma, Non-HodgkinLymphocytic LeukemiaMultiple Myeloma Eisai Korea Inc. 84
Early research (Phase 1)Looking for participantsNCT05010564What this trial is testingTrivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)Who this might be right forLeukemia, B-Cell Baylor College of Medicine 38
Large-scale testing (Phase 3)Study completedNCT03734016What this trial is testingZanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma BeiGene 652
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07624799What this trial is testingFixed Duration Treatment With Combined Pirtobrutinib and Short Course Immuno-chemotherapy in Fit Patients With Previously Untreated Symptomatic Chronic Lymphocytic Leukemia (CLL).Who this might be right forCLL (Chronic Lymphocytic Leukemia) French Innovative Leukemia Organisation 82
Testing effectiveness (Phase 2)Study completedNCT00103558What this trial is testingLumiliximab in Combination With FCR in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia Biogen 31
Large-scale testing (Phase 3)Ended earlyNCT00014326What this trial is testingInvolved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's LymphomaWho this might be right forLymphoma European Organisation for Research and Treatment of Cancer - EORTC 204
Very early researchEnded earlyNCT00020670What this trial is testingVaccine Therapy in Treating Patients With Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Dana-Farber Cancer Institute 9